OrangerLabs · Washington, DC · PepMed 2026
Meet us at PepMedMarketing for regulated health
We are a healthcare end-to-end marketing agency that helps you acquire, convert and scale… while staying compliant.
Strategy · Creative · Media · Funnels · Automation · Attribution
Advertising is only the beginning. The same signal has to survive the landing page, qualification, follow-up and booking.
A participant clears screening. A patient books an appointment. A consultation gets scheduled. That is the event we optimize toward.
Qualified patients up. Booked consults up. Cost per acquisition down. Healthcare metrics, connected back to the media that created them.
What we do
01
Paid search, social, content and targeting designed around qualified healthcare demand, not raw reach.
02
Screenings, consultations, appointments, patient registration and qualified opportunities.
03
Connect acquisition to downstream outcomes and move resources toward what creates actual business.
A campaign supported by consumer and compliance intelligence performs better.
Healthcare marketing is constrained by product status, claims, patient data, geography, channel rules and professional standards. We build those constraints into the acquisition strategy from the beginning.
Requirements vary by client, product, market and jurisdiction. Final medical, legal and regulatory approval remains with the client and its appropriate advisors.
Who we work with
Clinical-trial recruitment, patient acquisition and product communication.
Participant acquisition and qualified screening at scale.
Build predictable patient demand and convert it into booked care.
Demand generation, consultation funnels and patient lifecycle growth.
Education-first acquisition for complex and fast-evolving therapeutic categories.
Commercial growth built around the realities of regulated healthcare.
Acquire patients, providers and commercial partners through measurable growth systems.
If your marketing has to survive platform review, medical review and legal review before it reaches the customer, we are definitely built for you.
A pharmaceutical organization needed to accelerate recruitment for active clinical studies across multiple markets. The real objective was not generating the highest possible volume of leads. It was reaching people who matched study criteria and moving them efficiently into the screening process.
Clinical-trial acquisition creates a difficult marketing problem. Eligibility can be narrow, media can become expensive quickly, and every unqualified enquiry consumes recruitment resources. Campaigns also need to operate within advertising-platform requirements, patient privacy considerations and the study's approved recruitment framework.
OrangerLabs built the campaign around the qualified participant, not the lead.
We developed the acquisition strategy, campaign creative, landing experiences and pre-screening journey around study eligibility. Media sources were connected to downstream screening outcomes so campaigns could be optimized toward participants progressing through the recruitment process rather than toward inexpensive form submissions.
Automated follow-up and lead routing shortened the gap between initial interest and recruiter contact.
The campaign shifted optimization away from raw lead volume and toward qualified recruitment outcomes.
A Canadian healthcare organization wanted to acquire new patients and connect more people with physicians. Marketing demand had to translate into real appointments while supporting an operational process capable of handling the additional patient volume.
Patient acquisition was fragmented across advertising, follow-up, scheduling and intake. Manual processes and paper records slowed the journey after a patient expressed interest, creating unnecessary administrative work and additional opportunities for drop-off.
OrangerLabs connected acquisition and clinic operations into one patient journey.
Campaigns generated new patient enquiries. Automated follow-up moved patients toward booking. Digital scheduling reduced friction. Digital intake replaced paper forms and organized patient information before the appointment.
Growth did not stop when the lead arrived. The acquisition and administrative journey were redesigned together.
A physician-led health company wanted to capitalize on rapidly growing interest in peptide and regenerative medicine while presenting the category with the credibility expected of a serious medical organization.
Peptide marketing sits inside an unusually complicated environment. Patient demand is high. But product status, medical claims, physician oversight, compounding rules, advertising policies and jurisdictional differences can dramatically change what can be marketed, and how.
Simply running aggressive direct-response ads created unnecessary regulatory and platform risk and did not create the level of trust required for a medical consultation.
OrangerLabs built the acquisition system around education and consultation, not exaggerated product promises.
Campaigns introduced the relevant health problem or patient objective. Educational landing experiences provided context. Qualification flows guided prospective patients toward the appropriate consultation. Advertising, landing pages, follow-up and booking were treated as one connected acquisition system.
Messaging frameworks were adapted by product, platform and jurisdiction rather than forcing one campaign everywhere.
Demand was converted into a structured consultation funnel rather than a product-first advertising campaign.
If you are building in healthcare, medicine, clinical research or emerging therapeutics, talk to the team that understands why your growth strategy cannot look like everyone else's.
